Apoha emerges from stealth with $36M to build “Liquid State Intelligence” for molecular behaviour
Apoha, a deeptech company pioneering what it calls Liquid State Intelligence emerges from stealth today with $36 million in funding. The round is led by Singular, with participation from Tim Draper’s...
Advances in molecular understanding and computational capabilities are enabling new approaches to drug discovery and material science, attracting significant venture capital.
Apoha's work in 'Liquid State Intelligence' represents a novel, platform-level approach to understanding molecular behavior, potentially unlocking new frontiers in synthetic biology and drug development.
The emergence of new methodologies to analyze molecular interactions at a foundational level could accelerate the development of complex biological systems and therapies.
- · Biotech companies
- · Deeptech investors
- · Pharmaceutical industry
- · Synthetic biology researchers
- · Traditional drug discovery methods
- · Research reliant solely on static molecular models
Apoha will use its funding to further develop its 'Liquid State Intelligence' platform for molecular behavior analysis.
Successful application of this platform could lead to the discovery of new therapeutic targets and the engineering of novel biomaterials.
This could fundamentally alter drug discovery timelines and efficiency, making previously intractable biological problems solvable.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Tech.eu